01—Abstract
Summary
Summary of the 10-K filed February 8, 2023. Cited figures are marked; the original filing is the authoritative source.
3M Company's 2022 Form 10-K details a challenging year marked by significant legal charges and strategic restructuring, alongside ongoing operational impacts from global economic factors.
The company reported substantial legal expenses totaling $2.3 billiona, primarily related to the Combat Arms Earplugs litigation and environmental matters associated with PFAS, including a $0.8 billion pre-tax charge for exiting PFAS manufacturing. These factors significantly impacted profitability, with operating income down 11.3% year-over-year. Despite these headwinds, 3M executed strategic divestitures, including the split-off of its Food Safety business, and continued to invest in innovation and sustainability, with capital expenditures of $1.75 billion.
The company is also advancing its plan to spin off its Health Care business into a separate public entity, a move expected to enhance shareholder value by creating two more focused companies. Geographically, the Americas region showed resilience with a 1.7%b sales increase, while Asia Pacific and Europe experienced sales declines.
Management is focused on navigating these complex challenges by managing costs, optimizing its portfolio, and investing in future growth drivers. Investors should monitor the progress of the Health Care spin-off and the resolution of major legal and environmental liabilities, particularly those related to PFAS and earplug litigation, as these will be key determinants of future financial performance.
02—Key points
Key Highlights
- 3M reported significant "special items" impacting financial results, including $2.3 billion in pre-tax charges for litigation (Combat Arms Earplugs, PFAS-related matters) and $0.8 billion for exiting PFAS manufacturing.
- Total company net sales decreased by 3.2% to $34.2 billion in 2022, reflecting a challenging global economic environment and specific business headwinds.
- Operating income saw a substantial year-over-year decline of 11.3% to $6.5 billion, largely due to the aforementioned special items and increased raw material/logistics costs.
- The company announced its intention to spin off its Health Care business into a separate public company, a strategic move aimed at creating two focused entities.
- 3M completed the split-off of its Food Safety Division in a transaction that generated a pre-tax gain of $2.7 billion.
- The Safety and Industrial segment experienced a significant 51.4% drop in operating income, impacted by litigation charges, while other segments also saw declines in operating income.
- The company continues to manage raw material price inflation and supply chain disruptions, which significantly impacted cost of sales and manufacturing productivity.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2022, 3M Co kept $0.22.
- Revenue$26.16B100.0%
- Cost of revenue−$15.85B60.6%
- Gross profit$10.31B39.4%
- Operating costs−$5.94B22.7%
- Operating income$4.37B16.7%
- Interest, other & tax$1.41B5.4%
- Net income$5.78B22.1%
04—Financials
Financial Highlights
Figures from 10-KFY2022filed February 8, 2023Financial Statements
FY2022 against FY2021
| Line item | FY2022FY2021 | Change |
|---|---|---|
| Revenue | $26.16B$35.35B | −26.0% |
| Cost of Revenue | $15.85B$18.80B | −15.7% |
| Gross Profit | $10.31B$16.56B | −37.8% |
| R&D Expenses | $800.00M$1.20B | −33.3% |
| SG&A Expenses | $7.23B$7.20B | +0.5% |
| Operating Expenses | $21.79B$27.99B | −22.1% |
| Operating Income | $4.37B$7.37B | −40.7% |
| Interest Expense | $462.00M$488.00M | −5.3% |
| Net Income | $5.78B$5.92B | −2.4% |
| EPS (Basic) | $10.21$10.23 | −0.2% |
| EPS (Diluted) | $10.18$10.12 | +0.6% |
| Shares Outstanding (Basic) | 566.00M579.00M | −2.2% |
| Shares Outstanding (Diluted) | 567.60M585.30M | −3.0% |
05—Questions
Frequently Asked Questions
What were the major financial impacts from litigation and special items in 2022?
3M incurred significant special items in 2022, totaling approximately $2.3 billion pre-tax for litigation related to Combat Arms Earplugs and PFAS matters. Additionally, the company recorded an $0.8 billion pre-tax charge for exiting PFAS manufacturing by the end of 2025. These charges heavily impacted operating income and earnings per share.
What is the status of the Health Care business spin-off?
3M announced its intention to spin off its Health Care business into a separate public company. This transaction is intended to be tax-free for shareholders and is expected to be completed by year-end 2023, subject to customary conditions. 3M expects to initially retain a 19.9% ownership position in the spun-off entity.
How did the company's business segments perform in 2022?
Performance varied across segments. Safety and Industrial saw a significant drop in operating income due to litigation charges, while Transportation and Electronics was impacted by PFAS manufacturing exit costs. Health Care and Consumer segments also experienced declines in operating income. Overall, net sales decreased across most segments.
What are the key risks and challenges facing 3M in the near future?
Key risks highlighted in the filing include ongoing liabilities and potential future charges related to PFAS and the Combat Arms Earplugs litigation, which has led to the chapter 11 filing of Aearo entities. The company also faces risks related to global economic conditions, supply chain disruptions, foreign currency fluctuations, and the execution of its strategic initiatives, such as the Health Care spin-off.
06—Continue